UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000579
Receipt number R000000704
Scientific Title A psychosomatic study for the functions of ghrelin.
Date of disclosure of the study information 2010/03/31
Last modified on 2012/02/17 13:25:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A psychosomatic study for the functions of ghrelin.

Acronym

A psychosomatic study for the functions of ghrelin.

Scientific Title

A psychosomatic study for the functions of ghrelin.

Scientific Title:Acronym

A psychosomatic study for the functions of ghrelin.

Region

Japan


Condition

Condition

Eating disorder

Classification by specialty

Medicine in general Endocrinology and Metabolism Psychosomatic Internal Medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the relationship between feeding regulatory peptides and eating behaviours, psychological states and clinical courses in patients with eating disorder for elucidate the pathophysiology.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

feeding regulatory peptides(e.g.,ghrelin),
eating behaviour, nutritional change

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

Subjects for patient group are patients with eating disorder. Inpatients are participated from admission to six months after discharge and outpatients are participated for six months after first oral glucose tolerance test. The treatment consists of behavioral therapy, nutritional rehabilitation and medication.
Oral glucose tolerance test is administered before treatment, during treatment and after treatment.

Interventions/Control_2

Subjects for control group are healthy volunteers. Oral glucose tolerance test is administered.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Subjects for patient group are patients with eating disorder. Each clinical disorder is diagnosed on the basis of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition.

Key exclusion criteria

The subjects are excluded if they had a history of alcohol abuse, substance abuse,
gastrointestinal disease, diabetes mellitus or other metabolic diseases.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akio Inui

Organization

Kagoshima University Graduate School of Medical and Dental Sciences

Division name

Department of Behavioral Medicine

Zip code


Address

8-35-1, Sakuragaoka, Kagoshima-City 890-8520, Japan

TEL

099-275-5751

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kagoshima University Graduate School of Medical and Dental Sciences

Division name

Department of Behavioral Medicine

Zip code


Address

8-35-1, Sakuragaoka, Kagoshima-City 890-8520, Japan

TEL

099-275-5751

Homepage URL


Email



Sponsor or person

Institute

Kagoshima University Graduate School of Medical and Dental Sciences

Institute

Department

Personal name



Funding Source

Organization

the Japanese Ministry of Health, Labor and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2001 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2001 Year 04 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 01 Month 23 Day

Last modified on

2012 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000704


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name